Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,307 | 81 | 90.0% |
| Education | $144.84 | 3 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $171.44 | 12 | $0 (2021) |
| Amgen Inc. | $146.75 | 8 | $0 (2020) |
| Lilly USA, LLC | $142.27 | 10 | $0 (2020) |
| PFIZER INC. | $136.40 | 10 | $0 (2020) |
| Novo Nordisk Inc | $112.39 | 5 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.37 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $99.95 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $89.57 | 6 | $0 (2022) |
| GlaxoSmithKline, LLC. | $73.11 | 5 | $0 (2020) |
| Allergan, Inc. | $66.21 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $80.93 | 4 | ABBVIE INC. ($46.61) |
| 2021 | $77.70 | 4 | Allergan, Inc. ($29.99) |
| 2020 | $445.04 | 26 | Amgen Inc. ($75.90) |
| 2019 | $635.93 | 36 | Astellas Pharma US Inc ($99.95) |
| 2018 | $212.25 | 14 | PFIZER INC. ($48.00) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: VACCINE | ||||||
| 07/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2021 | Allergan, Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2021 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Vaccines | ||||||
| 12/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Diabetes | ||||||
| 11/03/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Respiratory | ||||||
| 10/20/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiology | ||||||
| 08/25/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/18/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: DIABETES | ||||||
| 08/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: RESPIRATORY | ||||||
| 07/28/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Bone Health | ||||||
| 07/01/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: PSYCHIATRY | ||||||
| 07/01/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/23/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 06/11/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: VACCINES | ||||||
| 05/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 184 | 276 | $30,605 | $12,456 |
| 2022 | 16 | 408 | 568 | $49,127 | $21,641 |
| 2021 | 14 | 454 | 602 | $47,378 | $22,313 |
| 2020 | 9 | 246 | 349 | $27,197 | $11,729 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 60 | $13,230 | $4,546 | 34.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $3,241 | $2,047 | 63.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 44 | $5,078 | $1,898 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,067 | $1,551 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $3,621 | $1,274 | 35.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,444 | $824.76 | 57.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 12 | 59 | $654.00 | $272.13 | 41.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 20 | $270.00 | $44.00 | 16.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $10,560 | $5,898 | 55.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 60 | $12,090 | $3,624 | 30.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 40 | 40 | $4,462 | $2,806 | 62.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,960 | $1,891 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $3,196 | $1,497 | 46.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 31 | $3,782 | $1,489 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $1,880 | $1,086 | 57.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 25 | 28 | $2,016 | $907.97 | 45.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 25 | 27 | $2,025 | $796.07 | 39.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 14 | 88 | $880.00 | $424.75 | 48.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $705.00 | $410.25 | 58.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 13 | $741.00 | $185.46 | 25.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 45 | 84 | $1,260 | $182.10 | 14.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 19 | $570.00 | $172.19 | 30.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 25 | 25 | $400.00 | $153.65 | 38.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $600.00 | $116.44 | 19.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 63 | 63 | $13,860 | $7,852 | 56.7% |
About Dr. Travis Shivers, MD
Dr. Travis Shivers, MD is a Family Medicine healthcare provider based in Pleasant View, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1023404258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Travis Shivers, MD has received a total of $1,452 in payments from pharmaceutical and medical device companies, with $80.93 received in 2022. These payments were reported across 84 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,307).
As a Medicare-enrolled provider, Shivers has provided services to 1,292 Medicare beneficiaries, totaling 1,795 services with total Medicare billing of $68,139. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Pleasant View, TN
- Active Since 04/14/2015
- Last Updated 10/02/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023404258
Products in Payments
- Ozempic (Drug) $112.39
- TRULICITY (Drug) $105.54
- VRAYLAR (Drug) $103.38
- FARXIGA (Drug) $85.40
- LYRICA (Drug) $67.91
- JANUVIA (Drug) $60.87
- REXULTI (Drug) $60.38
- EVENITY (Biological) $58.16
- TRELEGY ELLIPTA (Drug) $57.05
- JARDIANCE (Drug) $53.35
- BYDUREON (Drug) $43.98
- Aimovig (Biological) $40.13
- CHANTIX (Drug) $38.86
- Repatha (Biological) $36.28
- STIOLTO RESPIMAT (Drug) $36.12
- Trintellix (Drug) $30.96
- PREVNAR - 13 (Biological) $29.63
- SYMBICORT (Drug) $29.43
- UBRELVY (Drug) $25.37
- XARELTO (Drug) $19.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Pleasant View
Darek Eggleston, Do, DO
Family Medicine — Payments: $6,259
Dr. Alicia Jackson, D.o, D.O
Family Medicine — Payments: $3,161
Mr. John Pennington, M.d, M.D
Family Medicine — Payments: $3,128
Van Christiansen, Md, MD
Family Medicine — Payments: $2,875
Carolyn Belfry, Md, MD
Family Medicine — Payments: $2,724
Dr. Shannah Steel, D.o, D.O
Family Medicine — Payments: $790.27